| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |